Insero enters licensing deals to produce Huperzine
Huperzine, sourced from a naturally occurring botanical extract, is used as a treatment for memory loss and other disorders. The company also licensed key patents from Harvard University
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.